- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 92,830 | 08.07.24 13:24:52 | +1,530 | +1,68% | 92,740 | 92,800 | 91,270 | 91,300 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 960,200 | 08.07.24 11:52:24 | +16,800 | +1,78% | 954,600 | 960,600 | 951,400 | 943,400 |
